Esketamine Nasal Spray versus Quetiapine for Resistant Depression. | N Engl J Med;390(1): 93, 2024 Jan 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

Esketamine Nasal Spray versus Quetiapine for Resistant Depression.

Horowitz, Mark A; Plöderl, Martin; Naudet, Florian.

Affiliation

Horowitz MA; North East London NHS Foundation Trust, London, United Kingdom mark.horowitz@nelft.nhs.uk.
Plöderl M; Paracelsus Medical University Salzburg, Salzburg, Austria.
Naudet F; University of Rennes, Rennes, France.

N Engl J Med ; 390(1): 93, 2024 Jan 04.

Article in En | MEDLINE | ID: mdl-38169502

Subject(s)

Depression; Nasal Sprays; Humans; Quetiapine Fumarate/therapeutic use; Depression/drug therapy; Antidepressive Agents/therapeutic use

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depression / Nasal Sprays Limits: Humans Language: En Journal: N Engl J Med / N. Engl. j. med / New England journal of medicine Year: 2024 Type: Article Affiliation country: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depression / Nasal Sprays Limits: Humans Language: En Journal: N Engl J Med / N. Engl. j. med / New England journal of medicine Year: 2024 Type: Article Affiliation country: United kingdom